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Surgical Techniquespassed behind the heart to reach the IVC (Figure 1).
A ringed polytetrafluoroethylene (Gore-Tex) conduit was
used to mitigate against compression by the heart. Warfarin
was given for 6 months postoperatively with a goal interna-
tional normalized ratio of 1.5 to 2.0, followed by aspirin
therapy alone. One year after discharge, an echocardiogram
showed unobstructed conduit flow.
DISCUSSION
Takedown of a Glenn shunt has been reported, but it is
uncommon. In particular, there is a paucity of information
on take-down and reconstruction of a left-sided Glenn in pa-
tients with atrial situs solitus.1,2 Coloni and colleagues3 de-
scribe using ringed and non-ringed PTFE grafts, as well as
a conduit made from autologous or bovine pericardium to
reconstruct the SVC and left brachiocephalic veins. Mahesh
and Ratnatunga4 reported reconstruction of the SVC with
aortic and pulmonary homograft in patients with SVC
occlusion due to benign or malignant pathology.
CONCLUSIONS
The technique we have described is most relevant in the
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982 The Journal of Thoracic and Cardiovascular Surganteriorly located conduit used for reconstruction of the left
SVC has the greatest potential to be problematic. The major
disadvantage to the technique we describe is the potential
for thrombosis in the relatively long, small-caliber PTFE
(Gore-Tex) graft. As has been our practice with patients
undergoing Fontan by the extracardiac conduit technique,
we plan to anticoagulate with warfarin (international nor-
malized ratio, 2.0) for approximately 6 months and then
transition to aspirin.
The authors thank Dr Irving Tessler for providing the medical
illustration.References
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345-7.Venovenous extracorporeal membrane oxygenation using a single
cannula in patients with pulmonary hypertension and atrial septal
defectsJeffrey Javidfar, MD,a Daniel Brodie, MD,b Joshua Sonett, MD,a and Matthew Bacchetta, MD,a New York,
NYAdults with unrepaired congenital septal defects are at risk
of developing Eisenmenger’s syndrome, characterized by
pulmonary hypertension and right ventricular failure. If
such patients fail medical therapy and acute on chronic
cardiopulmonary failure develops, they can be supported
with venoarterial extracorporeal membrane oxygenation
(ECMO) until they recover or receive a transplant.1Standard approaches to venoarterial ECMO require both
venous and arterial cannulation. In addition to requiring
a second cannula, without a concomitant ancillary ante-
grade catheter, peripheral arterial cannulation is associated
with the risk of limb ischemia.
The Avalon Elite Bicaval Dual Lumen catheter (Avalon
Laboratories, LLC, Rancho Domingez, Calif) allows for
adult venovenous ECMO through a single cannulation
site.2 The catheter has a right atrial infusion port that can
take advantage of the congenital atrial septal defect
(ASD) (Figure 1) and shunt oxygenated blood into the left
side of the heart while the other lumen drains the venae
cavae.2 Camboni and colleagues3 confirmed right to left
atrial shunting of oxygenated blood when using this cannula
for ECMO in sheep. We present the novel use of this cath-
eter to provide venovenous ECMOwith a physiologic shunt
and right ventricular decompression without an arterial
cannula.ery c April 2012
FIGURE 1. A dual lumen ECMO catheter with a right atrial infusion port
(blue arrow).
Surgical TechniquesCLINICAL SUMMARY
Two adults with secundum ASDs and Eisenmenger’s
syndrome were selected for this modified cannulation
technique after conventional medical therapy failed to treat
their acute decompensations. Both patients were on the
transplant list. Patient 1 was admitted to the intensive care
unit (ICU) in respiratory failure with elevated pulmonary
artery pressures. After another pulmonary hypertensive cri-
sis, cardiopulmonary arrest occurred and she was taken to
the operating room for emergency ECMO cannulation.
Patient 2 presented with hemoptysis refractory to emboliza-
tion of aortopulmonary collaterals. On admission, she had
suprasystemic pulmonary artery pressures. While on in-
haled nitric oxide in the ICU, she had ongoing hemoptysis
and an arterial oxygen desaturation to 60%. She progressed
to respiratory failure and was placed on ECMO as a bridge
to transplant.
A 23F Avalon Elite (Avalon Laboratories, LLC) was
inserted into the right internal jugular vein of each patient
under standard image guidance.2 Transesophageal echo-
cardiogram was used to ensure that the cannula’s right
atrial infusion port was positioned with flows directed
across the ASD (Figure 2). Each cannula was attachedThe Journal of Thoracic and Cato a standard venovenous ECMO circuit. Improvements
in pulmonary artery pressure and right ventricular unload-
ing were confirmed on transesophageal echocardiogram
before securing the catheter in place. Afterward, the pa-
tients were managed on ECMO according to established
low-dose anticoagulation and lung-protective ventilation
protocols.4
RESULTS
Adequate flows, good gas exchange, improved hemody-
namics, and ventricular decompression were immediately
recorded (Table 1). Both patients had an uncomplicated
ECMO course. Patient 1 recovered after resting on veno-
venous ECMO for 23 days. She remained neurologically
intact despite her cardiopulmonary arrest and was
weaned from the ventilator. She was discharged from
the ICU and lived 4 months before dying of an episode
of acute pneumonia. Patient 2 was extubated on ECMO
shortly after cannulation. After 6 days on venovenous
ECMO, she was bridged to double lung transplantation
with ASD repair. The patient did not require ECMO post-
transplant. She was discharged from the hospital with im-
proved right heart function and has returned to normal
activities.
CONCLUSIONS
Venovenous ECMO with the Avalon Elite can be used as
a bridge to recovery or transplantation in adults with ASDs
presenting with exacerbations of chronic lung disease and
right heart failure. Both patients were extubated and
ultimately weaned from mechanical circulatory support.
For patient 2, the benefits of early extubation while still
on ECMO included markedly less sedation requirements,
resumption of traditional enteral intake, increased mobility,
participation in physical therapy, and avoidance of a ventila-
tory associated pneumonia.
The unique physiology of these patients, including the
markedly elevated pulmonary artery pressures, requires
that oxygenated blood reach the left side of the heart.
This was accomplished with one cannula by directing
flow across the ASD, thereby creating an oxygenated
physiologic right to left shunt. This form of venovenous
ECMO offers patients improved oxygenation while par-
tially unloading the right side of the heart, without the
complications associated with standard peripheral arterial
cannulation.
Although this technique was performed in only 2 pa-
tients, these results show that the concept is feasible. The
single-site approach mimics venoarterial ECMO through
venovenous cannulation, but requires a preexisting congen-
ital atrial defect. Both in patients with Eisenmenger’s
syndrome who do not have an ASD and in other patients
with severe pulmonary artery hypertension, an atrial blade
septostomy should be considered.3,5 By percutaneouslyrdiovascular Surgery c Volume 143, Number 4 983
FIGURE 2. The right atrial infusion port (blue arrow) shunts oxygenated blood across the ASD (white arrow).
TABLE 1. Patients with congenital pulmonary hypertension
Demographics Respiratory parameters* Cannula performance measurements
Patient 1 Pre-ECMO During ECMO
Age 41 y PAO2:FIO2 ratio 36
Body mass index 14 pH 7.43 7.48 Cannula size 23F
PCO2 (mm Hg) 52 46 Days of pre-ECMO intubation 0
PAO2 (mm Hg) 36 79 Duration of ECMO support (d) 23
SAO2 64% 92% Median ECMO flow rates (L/min) 2.4 (2.1–2.6)
Systemic blood pressure (mm Hg) Arrest 125/55 pRBC transfused (units)z 7
Pulmonary artery pressure
(mm Hg)x
100/66 58/17 Platelets transfused (mL)z 643
Evidence of right ventricular
decompression on
echocardiogram
No Yes EBL during cannulation (mL) 25
Patient 2y Pre-ECMO During EMCO
Age 22 y PAO2:FIO2 ratio 60
Body mass index 17 pH 7.36 7.38 Cannula size 23F
PCO2 (mm Hg) 41 41 Days of pre-ECMO intubation 0.5
PAO2 (mm Hg) 60 108 Duration of ECMO support (d) 6
SAO2 75% 98% Median ECMO flow rates (L/min) 2.6 (2.3–2.8)
Systemic blood pressure (mm Hg) 92/40 133/57 pRBC transfused (units)z 0
Pulmonary artery pressure
(mm Hg)x
116/66 35/17 Platelets transfused (mL)z 0
Evidence of right ventricular
decompression on
echocardiogram
No Yes EBL during cannulation (mL) 50
PAO2, Arterial oxygen tension; FIO2, fraction of inspired oxygen; SAO2, arterial oxygen saturation; pRBC, packed red blood cells; EBL, estimated blood loss. *Median values.
yPre-lung transplant values. zDuring entire ECMO run. xBoth patients experienced a pulmonary hypertensive crisis.
Surgical Techniquescreating an ASD, a surgeon can offer venovenous
ECMO with a physiologic shut and right ventricular
decompression to larger patient populations, while using
a single cannulation site.
References
1. Belohlavek J, Rohn V, Jansa P, et al. Veno-arterial ECMO in severe acute right
ventricular failure with pulmonary obstructive hemodynamic pattern. J Invasive
Cardiol. 2010;22:365-9.984 The Journal of Thoracic and Cardiovascular Surg2. Javidfar J, Brodie D,Wang D, et al. Use of bicaval dual-lumen catheter for adult ve-
novenous extracorporealmembrane oxygenation.AnnThoracSurg. 2011;91:1763-9.
3. Camboni D, Akay B, Sassalos P, et al. Use of venovenous extracorporeal mem-
brane oxygenation and an atrial septostomy for pulmonary and right ventricular
failure. Ann Thorac Surg. 2011;91:144-9.
4. Brodie D, Bacchetta M. Extracorporeal membrane oxygenation for ARDS in
adults. N Engl J Med. 2011;365:1905-14.
5. Seib PM, Faulkner SC, Erickson CC, et al. Blade and balloon atrial septostomy
for left heart decompression in patients with severe ventricular dysfunction on
extracorporeal membrane oxygenation. Catheter Cardiovasc Interv. 1999;46:
179-86.ery c April 2012
